GSK recalls Grand-Pa batches

Comment on this story

Johannesburg - GlaxoSmithKline, the company that makes Grand-Pa, is recalling some batches of the headache medicine in South Africa after some were found to be counterfeit.

“The affected product should not be used as counterfeit medicines are not subject to the rigorous safety and quality checks by GSK, as is the case for genuine Grand-Pa powders,” the company said in a statement on Thursday.

The counterfeit products are being sold as Grand-Pa Powders, 38-count, and have batch numbers 309339 and 314020.

The counterfeit powder is being sold in packaging that has subtle differences from the genuine product. The fakes have spelling errors in the text on the package. For example, the word “koors” is misspelled “kors”.

The company said it was testing the counterfeit powder at its laboratories in the United Kingdom to establish the contents of the fake product.

GSK said it was voluntarily recalling its own products bearing those batch numbers in an effort to protect consumers.

It asks that consumer call its help line, 0800-118274, if they have queries or need assistance. - Sapa

sign up

Comment Guidelines

  1. Please read our comment guidelines.
  2. Login and register, if you haven’ t already.
  3. Write your comment in the block below and click (Post As)
  4. Has a comment offended you? Hover your mouse over the comment and wait until a small triangle appears on the right-hand side. Click triangle () and select "Flag as inappropriate". Our moderators will take action if need be.

  5. Verified email addresses: All users on Independent Media news sites are now required to have a verified email address before being allowed to comment on articles. You are only required to verify your email address once to have full access to commenting on articles. For more information please read our comment guidelines